Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Humblet

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Structure (London, England : 1993)|April 15, 1996
X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamilyV Dhanaraj, Q Z Ye, L L Johnson, et al.
Journal of Medicinal Chemistry|July 21, 1995
Design and synthesis of renin inhibitors: incorporation of transition-state isostere side chains that span from the S1 to the S3 binding pockets and examination of P3-modified renin inhibitorsM S Plummer, A Shahripour, J S Kaltenbronn, et al.
Journal of Medicinal Chemistry|March 20, 1992
Renin inhibitors containing alpha-heteroatom amino acids as P2 residuesJ T Repine, J S Kaltenbronn, A M Doherty, et al.
Journal of Medicinal Chemistry|July 1, 1991
Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonateJ T Repine, R J Himmelsbach, J C Hodges, et al.
Drug Design and Discovery|April 1, 1996
Hydrophobic D-amino acids in the design of peptide ligands for the pp60src SH2 domainM S Plummer, E A Lunney, K S Para, et al.
Bioorganic & Medicinal Chemistry|January 1, 1997
Design of peptidomimetic ligands for the pp60src SH2 domainM S Plummer, E A Lunney, K S Para, et al.
Protein Science : a Publication of the Protein Society|July 28, 1999
X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivityA G Pavlovsky, M G Williams, Q Z Ye, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Structure-based design of caspase-1 inhibitor containing a diphenyl ether sulfonamideA B Shahripour, M S Plummer, E A Lunney, et al.
Journal of Medicinal Chemistry|November 26, 1997
4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV proteaseB D Tait, S Hagen, J Domagala, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitorJ V Prasad, F E Boyer, J M Domagala, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Structure (London, England : 1993)|April 15, 1996
X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamilyV Dhanaraj, Q Z Ye, L L Johnson, et al.
Journal of Medicinal Chemistry|July 21, 1995
Design and synthesis of renin inhibitors: incorporation of transition-state isostere side chains that span from the S1 to the S3 binding pockets and examination of P3-modified renin inhibitorsM S Plummer, A Shahripour, J S Kaltenbronn, et al.
Journal of Medicinal Chemistry|March 20, 1992
Renin inhibitors containing alpha-heteroatom amino acids as P2 residuesJ T Repine, J S Kaltenbronn, A M Doherty, et al.
Journal of Medicinal Chemistry|July 1, 1991
Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonateJ T Repine, R J Himmelsbach, J C Hodges, et al.
Drug Design and Discovery|April 1, 1996
Hydrophobic D-amino acids in the design of peptide ligands for the pp60src SH2 domainM S Plummer, E A Lunney, K S Para, et al.
Bioorganic & Medicinal Chemistry|January 1, 1997
Design of peptidomimetic ligands for the pp60src SH2 domainM S Plummer, E A Lunney, K S Para, et al.
Protein Science : a Publication of the Protein Society|July 28, 1999
X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivityA G Pavlovsky, M G Williams, Q Z Ye, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Structure-based design of caspase-1 inhibitor containing a diphenyl ether sulfonamideA B Shahripour, M S Plummer, E A Lunney, et al.
Journal of Medicinal Chemistry|November 26, 1997
4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV proteaseB D Tait, S Hagen, J Domagala, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitorJ V Prasad, F E Boyer, J M Domagala, et al.
Pageof 8